Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
01/09/2013 | CN102863370A Novel synthetic method of antiepileptic drug levetiracetam |
01/09/2013 | CN102863350A Anti-inflammatory analgesia mutual prodrug of non-steroidal antiinflammatory drug and preparation method thereof |
01/09/2013 | CN102863348A Synthesis method of palmitoyl amino acid sodium |
01/09/2013 | CN102863345A Amino propylene glycol derivative, preparation method of amino propylene glycol derivative, medicine composition of amino propylene glycol derivative and application of amino propylene glycol derivative |
01/09/2013 | CN102093280B Preparation method of levetiracetam |
01/09/2013 | CN101622228B Method for producing (meth)acrylic esters of n-hydroxyalkylated lactams |
01/08/2013 | US8350056 Functionalized N-substituted pyrrolidonium ionic liquids |
01/08/2013 | CA2696826C Process for preparing inhibitors of nucleoside metabolism |
01/08/2013 | CA2546653C 3-aminopyrrolidone derivatives |
01/08/2013 | CA2478731C Carbamates as hiv protease inhibitors |
01/08/2013 | CA2447671C Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
01/03/2013 | WO2013002224A1 Cinnamic acid derivative, polymer thereof, and liquid crystal alignment layer comprising hardened product of said polymer |
01/03/2013 | US20130005988 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
01/03/2013 | US20130005790 Inorganic salt complexes of vildagliptin |
01/03/2013 | US20130004860 Quaternary ammonium salt and composition, and electrochemical device |
01/03/2013 | US20130004667 Compositions comprising a reactive monomer and with a urea or urethane functional group |
01/03/2013 | US20130004518 Cyclic amine bace-1 inhibitors having a benzamide substituent |
01/02/2013 | EP2540706A2 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates |
01/02/2013 | EP2540705A2 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates |
01/02/2013 | EP2540704A2 Benethamine salt forms of atorvastatin |
01/02/2013 | EP2539323A1 Compounds as bradykinin b1 antagonists |
01/02/2013 | EP2539317A2 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof |
01/02/2013 | CN102858740A Production of atorvastatin low in lactone impurities |
01/02/2013 | CN102858739A A process for amidation of pyrrole carboxylate compounds |
01/02/2013 | CN102850253A Method for refining and molding N-phenylmaleimide |
01/02/2013 | CN102850252A Preparation method for 3,5,5'-trisubstituted hydantoin |
01/02/2013 | CN102850251A Dipyrromethene compound synthetic method |
01/02/2013 | CN102850250A Preparation method of proline nitrate |
01/02/2013 | CN102363607B Method for synthesizing maleimide by using strongly acidic room-temperature ionic liquid as medium |
01/02/2013 | CN102311376B Preparation process of atorvastatin calcium |
01/02/2013 | CN102161546B Method for processing production effluent of maleimide compound |
01/02/2013 | CN101193860B 有机化合物 Organic compounds |
01/02/2013 | CN101184405B Beverages and foodstuffs resistant to light induced flavour changes, processes for making the same, and compositions for imparting such resistance |
01/02/2013 | CN101119963B Methamphetamine derivatives and conjugates for immunoassay |
01/02/2013 | CN101087757B Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them |
01/01/2013 | US8344162 Synthetic processes for the preparation of aminocyclohexyl ether compounds |
01/01/2013 | US8344161 Process for the preparation of pyrollidine-3-carboxylic acids |
01/01/2013 | US8343988 Inhibitors of histone deacetylase |
01/01/2013 | US8343963 Sulfamoyl-phenyl-ureido compounds and their use as medicament |
12/27/2012 | WO2012175962A1 COMPOUNDS FOR USE IN STABILISING p53 MUTANTS |
12/27/2012 | WO2012174926A1 N-substituted isopropyldimethyl azulene sulfonamide derivatives, and preparation method and use thereof |
12/27/2012 | US20120330019 Hepatitis C Virus Inhibitors |
12/27/2012 | US20120328985 Fluorine-Containing Sulfonate Resin, Fluorine-Containing N-Sulfonyloxyimide Resin, Resist Composition and Pattern Formation Method |
12/27/2012 | US20120325748 Antimicrobial water treatment membranes and production thereof |
12/26/2012 | EP2537829A1 Aminobenzoylsulfamides and their preparation |
12/26/2012 | EP2537827A1 Process for preparing 4-amino-5-hexenoic acid from succinimide |
12/26/2012 | EP2536711A1 5-ht receptor modulators |
12/26/2012 | EP2536687A2 Process for synthesis of 2-substituted pyrrolidines and piperadines |
12/26/2012 | EP2536686A1 Cyclic keto-enols for therapy |
12/26/2012 | CN102844313A Compositions and methods for enhancing proteasome activity |
12/26/2012 | CN102844300A Cyclic keto-enols for therapy |
12/26/2012 | CN102844299A Pesticidal arylpyrrolidines |
12/26/2012 | CN102838983A Maleimide fluorescence sensor including trifluoroacetamide and preparation method |
12/26/2012 | CN102838523A Anti-enterovirus 71 (EV71) valerolactam compounds, preparation method and uses thereof |
12/26/2012 | CN102838522A Chiral pyrroline synthetic method by palladium-catalyzed asymmetric hydrogenation |
12/26/2012 | CN102838521A Preparation method of dehydro-odorin |
12/26/2012 | CN102838520A Amisulpride preparation method |
12/26/2012 | CN102838437A Production method of amino-acid ester |
12/25/2012 | US8338622 Heterocyclic compound |
12/25/2012 | US8338621 Process for the preparation of 2-oxo-1-pyrrolidine derivatives |
12/25/2012 | US8338620 Methods for the production of C-8 lactam lactone compounds |
12/25/2012 | US8338440 Inhibitors of IAP |
12/20/2012 | WO2012174511A1 2-methylthiopyrrolidines and their use for modulating bacterial quorum sensing |
12/20/2012 | WO2012173572A1 Stereoselective synthesis of highly substituted enamides |
12/20/2012 | WO2012148252A3 Metformin-based ionic co-crystals |
12/20/2012 | US20120323018 Preparation of Monomers for Grafting to Polyolefins, and Lubricating Oil Compositions Containing Grafted Copolymer |
12/20/2012 | US20120323012 4-(azacycloalkyl) -benzene-1,3-diol derivatives as tyrosinase inhibitors and their synthesis and use thereof |
12/20/2012 | US20120322833 Pesticidal Arylpyrrolidines |
12/20/2012 | US20120322761 Heterocyclic cetp inhibitors |
12/20/2012 | US20120322066 Development of Novel Detergents for Use in PCR Systems |
12/20/2012 | US20120321560 Method for Obtaining Novel Derivatives of Naphthalene for the In Vivo Diagnosis of Alzheimer's Disease |
12/19/2012 | EP2534158A1 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity |
12/19/2012 | EP2534133A2 Biphenyl substituted cyclical keto-enols |
12/19/2012 | EP2534132A1 Substituted pyrrolidine-2-carboxamides |
12/19/2012 | CN202610137U Proline extraction device |
12/19/2012 | CN1926103B Sulphonylpyrroles as HDAC inhibitors |
12/19/2012 | CN102834378A Biphenyl substituted cyclical keto-enols |
12/19/2012 | CN102827895A Double-liquid-phase fermentation method of coupling in-situ extraction antrodia camphorate active product antrondin C |
12/19/2012 | CN102827060A Synthetic method of 5-trifluoromethyl pyrrole-2-formic acid |
12/19/2012 | CN102827059A Production method for N-tert-butoxycarbonylation-L-ethyl-pyroglutamic acid |
12/19/2012 | CN102827058A Production method of N-t-butoxycarbonyl-L-pyroglutamate |
12/19/2012 | CN102827057A Production method of ethyl L-pyroglutamate |
12/19/2012 | CN102827056A N-aryl-substituted pyrrolidone derivative and application thereof |
12/19/2012 | CN102827055A Method for preparing t-butyloxycarboryl-N-4-oxo-proline |
12/19/2012 | CN102827054A Hapten of L-hydroxyproline, artificial antigen, monoclonal antibody, preparation method and application |
12/19/2012 | CN101421218B Cycloalkyl-phenylsubstituierte cyclische ketoenole |
12/18/2012 | US8334316 Substituted organosulfur compounds and methods of using thereof |
12/18/2012 | US8334300 C2-phenyl-substituted cyclic ketonols |
12/18/2012 | CA2702933C Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof |
12/18/2012 | CA2553343C Aspartates useful as components in coating compositions and their preparation |
12/18/2012 | CA2533812C Substituted cycloalkylidene compounds |
12/13/2012 | WO2012170908A1 Design and development of novel detergents for use in pcr systems |
12/13/2012 | WO2012170035A1 Surfactants with a terminal dialkyl- or cycloalkyl-substituted tertiary amine and inks including the same |
12/13/2012 | WO2012169575A1 Method for manufacturing optically active carboxylic acid ester |
12/13/2012 | WO2012167413A1 Method for preparing optically pure (-)-clausenamide compound |
12/13/2012 | WO2012138254A3 Pharmacologically active 4,4'-biphenylamide derivatives and drugs based thereon |
12/13/2012 | US20120316193 Proteostasis regulators |
12/12/2012 | EP2531487A1 Aryl benzylamine compounds |
12/12/2012 | CN102822163A Crth2 modulators |
12/12/2012 | CN102822131A Rare-earth metal complex |